↓ Skip to main content

Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension

Overview of attention for book
Cover of 'Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Perspective for Part I
  3. Altmetric Badge
    Chapter 2 The Alveolar Stem Cell Niche of the Mammalian Lung
  4. Altmetric Badge
    Chapter 3 Lung Development and Notch Signaling
  5. Altmetric Badge
    Chapter 4 Specialized Smooth Muscle Cell Progenitors in Pulmonary Hypertension
  6. Altmetric Badge
    Chapter 5 Diverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary Hypertension
  7. Altmetric Badge
    Chapter 7 Extracellular Vesicles, MicroRNAs, and Pulmonary Hypertension
  8. Altmetric Badge
    Chapter 8 Roles of Tbx4 in the Lung Mesenchyme for Airway and Vascular Development
  9. Altmetric Badge
    Chapter 10 Roles of Stem Cell Antigen-1 in the Pulmonary Endothelium
  10. Altmetric Badge
    Chapter 11 Morphological Characterization of Pulmonary Microvascular Disease in Bronchopulmonary Dysplasia Caused by Hyperoxia in Newborn Mice
  11. Altmetric Badge
    Chapter 12 Involvement of CXCR4 and Stem Cells in a Rat Model of Pulmonary Arterial Hypertension
  12. Altmetric Badge
    Chapter 14 Perspective for Part II
  13. Altmetric Badge
    Chapter 15 Pathophysiology of Pulmonary Circulation in Congenital Heart Disease
  14. Altmetric Badge
    Chapter 16 Development of Novel Therapies for Pulmonary Hypertension by Clinical Application of Basic Research
  15. Altmetric Badge
    Chapter 17 Using Patient-Specific Induced Pluripotent Stem Cells to Understand and Treat Pulmonary Arterial Hypertension
  16. Altmetric Badge
    Chapter 19 Dysfunction and Restoration of Endothelial Cell Communications in Pulmonary Arterial Hypertension: Therapeutic Implications
  17. Altmetric Badge
    Chapter 21 Genotypes and Phenotypes of Chinese Pediatric Patients with Idiopathic and Heritable Pulmonary Arterial Hypertension: Experiences from a Single Center
  18. Altmetric Badge
    Chapter 22 Fundamental Insight into Pulmonary Vascular Disease: Perspectives from Pediatric PAH in Japan
  19. Altmetric Badge
    Chapter 23 Risk Stratification in Paediatric Pulmonary Arterial Hypertension
  20. Altmetric Badge
    Chapter 24 The Adaptive Right Ventricle in Eisenmenger Syndrome: Potential Therapeutic Targets for Pulmonary Hypertension?
  21. Altmetric Badge
    Chapter 25 Impaired Right Coronary Vasodilator Function in Pulmonary Hypertensive Rats Assessed by In Vivo Synchrotron Microangiography
  22. Altmetric Badge
    Chapter 26 Relationship Between Mutations in ENG and ALK1 Genes and the Affected Organs in Hereditary Hemorrhagic Telangiectasia
  23. Altmetric Badge
    Chapter 27 A Genetic Analysis for Patients with Pulmonary Arterial Hypertension
  24. Altmetric Badge
    Chapter 28 Evaluation and Visualization of the Right Ventricle Using Three-Dimensional Echocardiography
  25. Altmetric Badge
    Chapter 29 Pulmonary Hypertension Associated with Postoperative Tetralogy of Fallot
  26. Altmetric Badge
    Chapter 30 Microscopic Lung Airway Abnormality and Pulmonary Vascular Disease Associated with Congenital Systemic-to-Pulmonary Shunt
  27. Altmetric Badge
    Chapter 31 Respiratory Syncytial Virus Infection in Infants with Heart and Lung Diseases
  28. Altmetric Badge
    Chapter 32 Perspective for Part III
  29. Altmetric Badge
    Chapter 33 The Ductus Arteriosus, a Vascular Outsider, in Relation to the Pulmonary Circulation
  30. Altmetric Badge
    Chapter 34 Molecular, Genetic, and Pharmacological Modulation of the Ductus Arteriosus: KATP Channels as Novel Drug Targets
  31. Altmetric Badge
    Chapter 35 New Mediators in the Biology of the Ductus Arteriosus: Lessons from the Chicken Embryo
  32. Altmetric Badge
    Chapter 36 Constriction of the Ductus Arteriosus with KATP Channel Inhibitors
  33. Altmetric Badge
    Chapter 37 New Insights on How to Treat Patent Ductus Arteriosus
  34. Altmetric Badge
    Chapter 38 Antenatal Administration of Betamethasone Contributes to Intimal Thickening of the Ductus Arteriosus
  35. Altmetric Badge
    Chapter 39 Prostaglandin E-EP4-Mediated Fibulin-1 Up-regulation Plays a Role in Intimal Thickening of the Ductus Arteriosus
  36. Altmetric Badge
    Chapter 40 Transcriptional Profiles in the Chicken Ductus Arteriosus During Hatching
  37. Altmetric Badge
    Chapter 41 Inhibition of Cyclooxygenase Contracts Chicken Ductus Arteriosus
  38. Altmetric Badge
    Chapter 42 Prostaglandin E2 Receptor EP4 Inhibition Constricts the Rat Ductus Arteriosus
  39. Altmetric Badge
    Chapter 43 Dilatation of the Ductus Arteriosus by Diazoxide in Fetal and Neonatal Rats
  40. Altmetric Badge
    Chapter 44 The Effect of Long-term Administration of Prostaglandin E1 on Morphological Changes in Ductus Arteriosus
  41. Altmetric Badge
    Chapter 45 Significance of SGK1 as a Protein Kinase Transcriptionally Regulated by ALK1 Signaling in Vascular Endothelial Cells
  42. Altmetric Badge
    Chapter 46 Fabrication of Implantable Human Arterial Graft by Periodic Hydrostatic Pressure
  43. Altmetric Badge
    Chapter 47 Optimum Preparation of Candida albicans Cell Wall Extra (CAWE) for the Mouse Model of Kawasaki Disease
  44. Altmetric Badge
    Chapter 48 Perspective for Part IV
  45. Altmetric Badge
    Chapter 49 Advances in the Second Heart Field
  46. Altmetric Badge
    Chapter 50 Novel Cardiac Progenitors for All Components of the Heart Except for the Right Ventricle
  47. Altmetric Badge
    Chapter 52 The Endocardium as a Master Regulator of Ventricular Trabeculation
  48. Altmetric Badge
    Chapter 54 Progress in the Generation of Multiple Lineage Human-iPSC-Derived 3D-Engineered Cardiac Tissues for Cardiac Repair
  49. Altmetric Badge
    Chapter 55 Quantification of Contractility in Stem Cell-Derived Cardiomyocytes
  50. Altmetric Badge
    Chapter 56 A Neurotrophic Factor Receptor GFRA2, a Specific Surface Antigen for Cardiac Progenitor Cells, Regulates the Process of Myocardial Compaction
  51. Altmetric Badge
    Chapter 57 Cardiac Cell Specification by Defined Factors
  52. Altmetric Badge
    Chapter 58 A Temporo-Spatial Regulation of Sema3c Is Essential for Interaction of Progenitor Cells during Cardiac Outflow Tract Development
  53. Altmetric Badge
    Chapter 59 Spatiotemporally Restricted Developmental Alterations in the Anterior and Secondary Heart Fields Cause Distinct Conotruncal Heart Defects
  54. Altmetric Badge
    Chapter 60 Significance of Transcription Factors in the Mechanisms of Great Artery Malformations
  55. Altmetric Badge
    Chapter 62 Establishment of Induced Pluripotent Stem Cells from Immortalized B Cell Lines and Their Differentiation into Cardiomyocytes
  56. Altmetric Badge
    Chapter 63 Establishment of an In Vitro LQT3 model Using Induced Pluripotent Stem Cells from LQT3 Patient-Derived Cardiomyocytes
  57. Altmetric Badge
    Chapter 64 Genetic Assessments for Clinical Courses of Left Ventricle Noncompaction
  58. Altmetric Badge
    Chapter 65 Elucidating the Pathogenesis of Congenital Heart Disease in the Era of Next-Generation Sequencing
Attention for Chapter 14: Perspective for Part II
Altmetric Badge

Citations

dimensions_citation
4 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Perspective for Part II
Chapter number 14
Book title
Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
Published by
Springer, Singapore, February 2020
DOI 10.1007/978-981-15-1185-1_14
Book ISBNs
978-9-81-151184-4, 978-9-81-151185-1
Authors

Toshio Nakanishi, Nakanishi, Toshio